AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimscan-M 1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Medishri Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimscan-M 1 Tablet SR

DiaBeta-Duo 1mg Extended Release tablet is an antidiabetic medication, a dual-action formulation for adult type 2 diabetes management. It regulates blood glucose levels. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking DiaBeta-Duo even with controlled blood sugar; discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are crucial. Hypoglycemia (low blood sugar) is a prevalent side effect, manifesting as sweating, dizziness, headache, or tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be limited due to its hypoglycemic effect. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections; weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your physician of any prior heart conditions before commencing treatment; it may be unsuitable. Pregnant or lactating individuals should consult their doctor. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function will be necessary.

Uses of Glimscan-M 1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimscan-M 1 Tablet SR:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid crushing, chewing, or fracturing it. Administer Glimscan-M 1 Tablet SR with a meal.

Common Side effects of Glimscan-M 1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimscan-M 1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Consume Glimscan-M 1 Tablet SR with a meal.

How Glimscan-M 1 Tablet SR works:

Glimscan-M SR, a single-tablet formulation, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimscan-M 1 Tablet SR with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimscan-M 1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated for patients using Glimscan-M 1 SR Tablet. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimscan-M 1 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimscan-M 1 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, a low initial dose of Glimscan-M 1 Tablet SR is typically recommended; however, it's contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimscan-M 1 Tablet SR :

Should you forget a Glimscan-M 1 Tablet SR dose, administer it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimscan-M 1 Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimscan-M 1 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimscan-M 1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimscan-M 1 Tablet SR and seek immediate medical attention.
Glimscan-M 1 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glimscan-M 1 Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimscan-M 1 Tablet SR use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Glimscan-M 1 Tablet SR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimscan-M 1 Tablet SR and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimscan-M 1 Tablet SR
41
MRP 50
18% off